Salivary gland transfer to prevent radiation-induced xerostomia: A systematic review and meta-analysis

Oral Oncology

Volumn 50, Issue 2, 2014, Pages 77-83

  Sood, Amit J ^a   Fox, Nyssa F ^a   O'Connell, Brendan P ^a   Lovelace, Tiffany L ^b   Nguyen, Shaun A ^a   Sharma, Anand K ^a   Hornig, Joshua D ^a   Day, Terry A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Head and neck cancer; Radiation induced xerostomia; Radiotherapy; Salivary gland transfer; Xerostomia

Indexed keywords

CLINICAL EFFECTIVENESS; FOLLOW UP; HUMAN; INCIDENCE; META ANALYSIS; ORAL SURGERY; PRIORITY JOURNAL; RADIATION INDUCED XEROSTOMIA; RADIATION INJURY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SALIVARY GLAND; SALIVARY GLAND TRANSFER; SALIVATION; SYSTEMATIC REVIEW; XEROSTOMIA;

HEAD AND NECK CANCER; RADIATION-INDUCED XEROSTOMIA; RADIOTHERAPY; SALIVARY GLAND TRANSFER; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; PATIENT SATISFACTION; RADIATION INJURIES; SALIVARY GLANDS; TREATMENT OUTCOME; XEROSTOMIA;

EID: 84891826247     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.10.010     Document Type: Review

References (73)

1. A. Jemal et al. Cancer statistics, 2006 CA Cancer J Clin 56 2 2006 106 130
2. A. Jemal et al. Cancer statistics, 2010 CA Cancer J Clin 60 5 2010 277 300
3. P. Dirix, S. Nuyts, and W. Van den Bogaert Radiation-induced xerostomia in patients with head and neck cancer: a literature review Cancer 107 11 2006 2525 2534
4. Shaha ARPS, Shasha D, Harrison LB. Head and Neck Cancer. Clinical Oncology, O.R. Lenhard RE Jr., editor, Gansler T2001, Atlanta, GA: American Cancer Society.
5. Ang GA, editor, Radiotherapy for Head and Neck Cancers, Indications and Techniques, vol. second ed., New York, NY: Lippincott Williams and Wilkins; 2002.
6. C.M. Eneroth, C.O. Henrikson, and P.A. Jakobsson Effect of fractionated radiotherapy on salivary gland function Cancer 30 5 1972 1147 1153
7. W.B. Wescott, E.N. Starcke, I.L. Shannon, and J.I. Thornby Alterations in whole saliva flow rate induced by fractionated radiotherapy AJR Am J Roentgenol 130 1978 145 149
8. I.H. Valdez Radiation-induced salivary dysfunction: clinical course and significance Spec Care Dentist 11 6 1991 252 255
9. L. Franzen et al. Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort Eur J Cancer 28 2-3 1992 457 462
10. O. Wijers, P. Levendag, and M. Braaksma et al. Patients: with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors Head Neck 24 2002 737 747
11. N. Jha et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space Radiother Oncol 66 3 2003 283 289
12. N. Jha et al. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia Head Neck 31 2 2009 234 243
13. J.M. Roesink et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region Int J Radiat Oncol Biol Phys 51 4 2001 938 946
14. P.M. Braam et al. Long-term parotid gland function after radiotherapy Int J Radiat Oncol Biol Phys 62 3 2005 659 664
15. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the radiation therapy oncology group (RTOG) and the european organization for research and treatment of cancer (EORTC) Int J Radiat Oncol Biol Phys 31 5 1995 1341 1346
16. A. Trotti et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 3 2003 176 181
17. G. Peng et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma Radiother Oncol 104 3 2012 286 293
18. B.H. Lok et al. Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes Int J Radiat Oncol Biol Phys 82 5 2012 1851 1857
19. S.M. McBride et al. Intensity-modulated versus conventional radiation therapy for oropharyngeal carcinoma: long-term dysphagia and tumor control outcomes Head Neck 2013
20. E.M. O'Sullivan, and I.J. Higginson Clinical effectiveness and safety of acupuncture in the treatment of irradiation-induced xerostomia in patients with head and neck cancer: a systematic review Acupunct Med 28 4 2010 191 199
21. J.B. Epstein et al. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer Head Neck 23 5 2001 389 398
22. S.A. Yeh et al. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone Int J Radiat Oncol Biol Phys 62 3 2005 672 679
23. M. Coval et al. Limited mouth opening, xerostomia and extensive caries after nasopharyngeal carcinoma Refuat Hapeh Vehashinayim 22 2 2005 20-3 84-5
24. N. Mohammadi et al. Evaluation of radiation-induced xerostomia in patients with nasopharyngeal carcinomas J Dent Res Dent Clin Dent Prospects 1 2 2007 65 70
25. V.W. Wu, M.T. Ying, and D.L. Kwong Evaluation of radiation-induced changes to parotid glands following conventional radiotherapy in patients with nasopharygneal carcinoma Br J Radiol 84 1005 2011 843 849
26. N. Jha et al. A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer (RTOG 0244) Int J Radiat Oncol Biol Phys 84 2 2012 437 442
27. J.K. Tuan et al. Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma Radiother Oncol 104 3 2012 305 311
28. H. Seikaly et al. Submandibular gland transfer: a new method of preventing radiation-induced xerostomia Laryngoscope 111 2 2001 347 352
29. M.S. Chambers et al. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management Head Neck 26 9 2004 796 807
30. S.P. Reddy et al. Parotid-sparing irradiation for cancer of the oral cavity: maintenance of oral nutrition and body weight by preserving parotid function Am J Clin Oncol 24 4 2001 341 346
31. A. Vissink et al. The causes and consequences of hyposalivation Ear Nose Throat J 67 3 1988 166-8 173-6
32. H.J. Guchelaar, A. Vermes, and J.H. Meerwaldt Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment Support Care Cancer 5 4 1997 281 288
33. J.A. Logemann et al. Effects of xerostomia on perception and performance of swallow function Head Neck 23 4 2001 317 321
34. K.E. Ohrn, Y.B. Wahlin, and P.O. Sjoden Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications Support Care Cancer 9 4 2001 247 257
35. J.M. Rieger et al. Functional outcomes related to the prevention of radiation-induced xerostomia: oral pilocarpine versus submandibular salivary gland transfer Head Neck 34 2 2012 168 174
36. S.B. Jensen et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact Support Care Cancer 18 8 2010 1061 1079
37. F.R. Burlage et al. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study Int J Radiat Oncol Biol Phys 70 1 2008 14 22
38. L. Berk Systemic pilocarpine for treatment of xerostomia Expert Opin Drug Metab Toxicol 4 10 2008 1333 1340
39. R.K. Wong et al. Phase 2 results from radiation Therapy oncology group study 0537: a phase 2/3 study comparing acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating early radiation-induced xerostomia Cancer 118 17 2012 4244 4252
40. D.L. Kwong et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function Cancer 101 7 2004 1584 1593
41. M.R. Vergeer et al. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program Int J Radiat Oncol Biol Phys 74 1 2009 1 8
42. S. Nangia et al. Selective nodal irradiation for head and neck cancer using intensity-modulated radiotherapy: application of RTOG consensus guidelines in routine clinical practice Int J Radiat Oncol Biol Phys 76 1 2010 146 153
43. W.S. Liu et al. Assessment of salivary function change in nasopharyngeal carcinoma treated by parotid-sparing radiotherapy Cancer J 12 6 2006 494 500
44. M. Lambrecht, D. Nevens, and S. Nuyts Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer Strahlenther Onkol 189 3 2013 223 229
45. J.B. Yu et al. Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer Int J Radiat Oncol Biol Phys 83 1 2012 e101 7
46. N. Daly-Schveitzer et al. Intensity-modulated radiation therapy (IMRT): toward a new standard for radiation therapy of head and neck cancer? Eur Ann Otorhinolaryngol Head Neck Dis 128 5 2011 241 247
47. S. Tribius, and C. Bergelt Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain? Cancer Treat Rev 37 7 2011 511 519
48. C.M. Nutting et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial Lancet Oncol 12 2 2011 127 136
49. S. Bhide et al. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site Med Dosim 32 3 2007 188 195
50. C.H. Clark et al. Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer Br J Radiol 82 979 2009 585 594
51. A.K. Anand et al. Can dose reduction to one parotid gland prevent xerostomia? - A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy Clin Oncol (R Coll Radiol) 18 6 2006 497 504
52. D.I. Rosenthal et al. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing Semin Oncol 31 6 Suppl 18 2004 25 28
53. K.S. Chao Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer Semin Radiat Oncol 12 1 Suppl 1 2002 20 25
54. K. Chao, and D.J. Markman A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results Int J Radiat Oncol Biol Phys 49 2001 907 916
55. A.B. Miah et al. The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT Radiother Oncol 106 3 2013 346 351
56. N. Lee et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 1 2002 12 22
57. N. Jha et al. Submandibular salivary gland transfer prevents radiation-induced xerostomia Int J Radiat Oncol Biol Phys 46 1 2000 7 11
58. Y. Zhang et al. Prevention of radiation-induced xerostomia by submandibular gland transfer Head Neck 34 7 2012 937 942
59. H. Trotter The surgical anatomy of the lymphatics of the head and neck Ann Otol Rhinol Laryngol 39 1930 384 397
60. H, R., Lymphatic system of the head and neck, ed. t. Tobias M1938: Edwards Brothers.
61. S.K. Mukherji, D. Armao, and V.M. Joshi Cervical nodal metastases in squamous cell carcinoma of the head and neck: what to expect Head Neck 23 11 2001 995 1005
62. S.J. Hassan, and E.A. Weymuller Jr. Assessment of quality of life in head and neck cancer patients Head Neck 15 6 1993 485 496
63. M.F. Freeman Transformations related to the angular and the square root Ann Math Statist 21 4 1950 607 611
64. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 3 1986 177 188
65. K. Al-Qahtani et al. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101 6 2006 753 756
66. H. Seikaly et al. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia Arch Otolaryngol Head Neck Surg 130 8 2004 956 961
67. X.K. Liu et al. Submandibular salivary gland transfer for the prevention of radiation-induced xerostomia in patients with nasopharyngeal carcinoma: 5-year outcomes Head Neck 33 3 2011 389 395
68. K.A. Pathak et al. Upfront submandibular salivary gland transfer in pharyngeal cancers Oral Oncol 40 9 2004 960 963
69. K. Bjordal et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC quality of life group Eur J Cancer 36 14 2000 1796 1807
70. R. Djan, and A. Penington A systematic review of questionnaires to measure the impact of appearance on quality of life for head and neck cancer patients J Plast Reconstr Aesthet Surg 66 5 2013 647 659
71. S.N. Rogers et al. A comparison between the University of Washington Head and Neck Disease-Specific measure and the Medical Short Form 36, EORTC QOQ-C33 and EORTC Head and Neck 35 Oral Oncol 34 5 1998 361 372
72. E.A. Weymuller Jr et al. Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R) Arch Otolaryngol Head Neck Surg 127 5 2001 489 493
73. I.J. Das et al. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems J Natl Cancer Inst 100 5 2008 300 307